Saving time in the emergency department with high-sensitivity troponin assays
Dr. Frank Peacock discusses the impact of delayed care in the ED setting, the power of high-sensitivity troponin assays, and the value of point of care
Dr. Frank Peacock discusses the impact of delayed care in the ED setting, the power of high-sensitivity troponin assays, and the value of point of care
The Ultreon 1.0 Software helps physicians automatically detect and quantify blood vessel characteristics, giving them better insights for optimal patient treatment
Watch world-leading scientists online, May 11-12, to discover the latest tools and techniques advancing COVID-19 research, immunotherapy development, drug screening, cancer diagnostics and more
The BinaxNOW Self-Test will be sold in 2-count packs for an MSRP of $23.99, making it an affordable over-the-counter COVID-19 rapid test available in the U.S.
The next-generation therapy offers enhanced leaflet grasping feature and new clip sizes to fit each patient's complex tricuspid valve anatomy
Amanda Kulwicki, Global Brand Manager at Thermo Fisher Scientific, discusses how her team ensures sample integrity with confidence
Lateral flow assays are empowering the fight against COVID-19 and in this article, experts in the field tell us more about this technology, highlighting recent advances and challenges
Catch up on this on-demand webinar and register for part 2 to learn everything you need to know to get ready for IVDR
Explore topics from immuno-oncology, Raman spectroscopy, in vitro diagnostics, and clinical research
Explore topics from immunoassays, immunotherapeutics and immuno-oncology to Raman spectroscopy, metabolomics, and COVID-19
Join thousands of scientists from around the world as they come together online to discuss the hottest topics and latest technology solutions
Newly FDA-approved system allows a patient to both communicate with a physician and remotely receive stimulation settings in real time regardless of location
The heart has a ‘natural backup pacemaker’ that can kick into action if the primary way the organ generates electrical signals fails
The partnership will pair Personalis’ NeXT tumor profiling with Natera’s Signatera™ for treatment monitoring